Cutter & CO Brokerage, Inc. Paratek Pharmaceuticals, Inc. Transaction History

Cutter & CO Brokerage, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.37 - $2.54 $14,933 - $27,686	10,900 New	10,900 $27,000
Q1 2022 May 03, 2022	SELL	$2.94 - $4.77 $32,046 - $51,992	-10,900 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$4.7 - $7.24 $1,880 - $2,896	400 Added 3.81%	10,900 $53,000
Q3 2020 Nov 05, 2020	SELL	$4.19 - $6.69 $7,018 - $11,205	-1,675 Reduced 13.76%	10,500 $57,000
Q2 2020 Aug 10, 2020	BUY	$2.97 - $5.22 $36,159 - $63,553	12,175 New	12,175 $64,000
Q3 2018 Oct 12, 2018	SELL	$9.05 - $10.95 $91,857 - $111,142	-10,150 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$10.2 - $13.9 $103,530 - $141,085	10,150 New	10,150 $104,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.